BridgeBio Oncology Therapeutics, Inc. (BBOT) short volume
BridgeBio Oncology Therapeutics, Inc. FINRA short-volume cache. Latest 2026-08-18.
| Date | Short | Total | Short % |
|---|---|---|---|
| 2026-08-18 | 119,156 | 133,218 | 89.4% |
| 2026-08-17 | 48,387 | 69,838 | 69.3% |
| 2026-08-14 | 44,622 | 60,352 | 73.9% |
| 2026-08-13 | 175,457 | 200,829 | 87.4% |
| 2026-08-12 | 33,815 | 52,107 | 64.9% |
| 2026-08-11 | 55,246 | 72,778 | 75.9% |
| 2026-08-10 | 31,431 | 50,928 | 61.7% |
| 2026-08-07 | 30,827 | 47,207 | 65.3% |
| 2026-08-06 | 24,088 | 71,370 | 33.8% |
| 2026-08-05 | 21,726 | 34,742 | 62.5% |
FAQ
What is BBOT P/E and revenue?
BridgeBio Oncology Therapeutics, Inc. (BBOT) $610.4M cap.
What is BBOT short volume?
BridgeBio Oncology Therapeutics, Inc. last cached short volume is 89.4% of total volume on 2026-08-18.
Not investment advice. Cached rows, not a live tape.